Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial.
Jakobsen L, Christiansen EH, Freeman P, Kahlert J, Veien K, Maeng M, Raungaard B, Ellert J, Villadsen AB, Kristensen SD, Christensen MK, Terkelsen CJ, Aaroe J, Thim T, Lassen JF, Hougaard M, Eftekhari A, Jensen RV, Støttrup NB, Rasmussen JG, Junker A, Jensen SE, Hansen HS, Jensen LO. Jakobsen L, et al. Among authors: kahlert j. EuroIntervention. 2023 Oct 23;19(8):676-683. doi: 10.4244/EIJ-D-23-00330. EuroIntervention. 2023. PMID: 37584207 Free article.
Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial).
Jensen LO, Maeng M, Raungaard B, Hansen KN, Kahlert J, Jensen SE, Hansen HS, Lassen JF, Bøtker HE, Christiansen EH. Jensen LO, et al. Among authors: kahlert j. EuroIntervention. 2018 Jan 20;13(13):1587-1590. doi: 10.4244/EIJ-D-17-00731. EuroIntervention. 2018. PMID: 28870882 Free article. Clinical Trial. No abstract available.
Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial.
Ellert J, Christiansen EH, Maeng M, Raungaard B, Jensen SE, Kristensen SD, Veien KT, Junker AB, Jakobsen L, Aarøe J, Terkelsen CJ, Kahlert J, Villadsen AB, Bøtker HE, Jensen LO. Ellert J, et al. Among authors: kahlert j. Catheter Cardiovasc Interv. 2019 Mar 1;93(4):567-573. doi: 10.1002/ccd.27891. Epub 2018 Sep 23. Catheter Cardiovasc Interv. 2019. PMID: 30244533 Clinical Trial.
Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial).
Maeng M, Christiansen EH, Raungaard B, Kahlert J, Terkelsen CJ, Kristensen SD, Carstensen S, Aarøe J, Jensen SE, Villadsen AB, Lassen JF, Thim T, Eftekhari A, Veien KT, Hansen KN, Junker A, Bøtker HE, Jensen LO; SORT OUT VIII Investigators. Maeng M, et al. Among authors: kahlert j. JACC Cardiovasc Interv. 2019 Apr 8;12(7):624-633. doi: 10.1016/j.jcin.2018.12.036. JACC Cardiovasc Interv. 2019. PMID: 30947936 Free article. Clinical Trial.
Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial.
Jensen LO, Maeng M, Raungaard B, Engstrøm T, Hansen HS, Jensen SE, Bøtker HE, Kahlert J, Lassen JF, Christiansen EH. Jensen LO, et al. Among authors: kahlert j. Am Heart J. 2019 Jul;213:1-7. doi: 10.1016/j.ahj.2019.02.017. Epub 2019 Mar 14. Am Heart J. 2019. PMID: 31055192 Clinical Trial.
Everolimus-Eluting Versus Biolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus.
Gyldenkerne C, Olesen KKW, Jensen LO, Junker A, Veien KT, Terkelsen CJ, Kristensen SD, Thim T, Jensen SE, Raungaard B, Aaroe J, Kahlert J, Villadsen AB, Bøtker HE, Christiansen EH, Maeng M. Gyldenkerne C, et al. Among authors: kahlert j. Am J Cardiol. 2019 Sep 1;124(5):671-677. doi: 10.1016/j.amjcard.2019.05.060. Epub 2019 Jun 6. Am J Cardiol. 2019. PMID: 31279405 Clinical Trial.
Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial.
Ellert J, Maeng M, Raungaard B, Hansen KN, Kahlert J, Jensen SE, Bøtker HE, Hansen HS, Lassen JF, Christiansen EH, Jensen LO. Ellert J, et al. Among authors: kahlert j. Coron Artery Dis. 2020 Sep;31(6):485-492. doi: 10.1097/MCA.0000000000000875. Coron Artery Dis. 2020. PMID: 32271243 Clinical Trial.
Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial.
Jensen Lisette Okkels, Maeng M, Raungaard B, Kahlert J, Ellert J, Jakobsen L, Villadsen AB, Veien KT, Kristensen SD, Ahlehoff O, Carstensen S, Christensen MK, Terkelsen CJ, Engstroem T, Hansen KN, Bøtker HE, Aaroe J, Thim T, Thuesen L, Freeman P, Aziz A, Eftekhari A, Junker A, Jensen SE, Lassen JF, Hansen HS, Christiansen EH; Sort Out IX Study Group. Jensen Lisette Okkels, et al. Among authors: kahlert j. Circulation. 2020 Jun 23;141(25):2052-2063. doi: 10.1161/CIRCULATIONAHA.119.040241. Epub 2020 May 21. Circulation. 2020. PMID: 32434381 Clinical Trial.
Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial.
Jakobsen L, Christiansen EH, Freeman P, Kahlert J, Veien K, Maeng M, Raungaard B, Ellert J, Villadsen AB, Kristensen SD, Ahlehoff O, Christensen MK, Terkelsen CJ, Erik Bøtker H, Aaroe J, Thim T, Thuesen L, Aziz A, Eftekhari A, Jensen RV, Støttrup NB, Rasmussen JG, Junker A, Jensen SE, Hansen HS, Jensen LO. Jakobsen L, et al. Among authors: kahlert j. Circulation. 2021 Jun;143(22):2155-2165. doi: 10.1161/CIRCULATIONAHA.120.052766. Epub 2021 Apr 7. Circulation. 2021. PMID: 33823606 Clinical Trial.
73 results